AQST: Aquestive Therapeutics Company Short-Term Debt

Symbol and logo of brand Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics (AQST) leverages the expertise of polymer chemists while recruiting specialized managers to scale sales. The business's prosperity is based on FDA approval and patent protection for mucosal adrenaline delivery systems. The current metric is 0.00. The price action on this chart confirms the stability of the company, which synthesizes films in-house and delegates only primary testing to external partners.

AQST (Aquestive Therapeutics Inc) Company Short-Term Debts history from 07/04/2022 to 10/31/2026

Analytical breakdowns and data insights for company Aquestive Corp (AQST)

- current quotes and average value forecast:
Price Chart Aquestive Therapeutics, Inc.|AQST - Fair Value Consensus
- market capitalization information:
Market Value Aquestive Therapeutics, Inc.|AQST - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Aquestive Therapeutics|AQST - Book Capitalization|Market Cap to Net Assets Ratio aquestive.com|AQST - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Aquestive Therapeutics|AQST - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Aquestive Therapeutics|AQST - Company Cumulative Indebtedness|Debts to Book Capitalization Aquestive Therapeutics, Inc.|AQST - Company Long-Term Loans and Borrowings|Company Short-Term Debts Aquestive Therapeutics|Quick Liquidity aquestive.com
- net income and valuation multiples indicators:
AQST - Final Profit
Summary company analytics:Aquestive Therapeutics, Inc. (AQST)
Mass-produced product of aquestive.com

Short-term debt represents the aggregate of all company obligations maturing within one year. This metric accumulates current loans and accrued interest, determining the issuer's liquidity and financial stability. Analyzing the short-term debt structure allows for tracking borrowing trends for working capital. For Aquestive Therapeutics (AQST), such funds are critical for paying external clinical research contractors. Manufacturing outsourcing requires stable funding for current payments.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings KVUE (Kenvue Inc)|Verona Pharma Corp (VRNA) - Company Short-Term Debt|Company Current Liabilities Jyong Bio|LGND (Ligand Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts amneal.com|Company Current Liabilities PRGO (Perrigo)|ALVO (Alvotech S.A.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Liquidia Technologies LQDA|Galapagos Corp (GLPG) - Short-Term Debt|ANIP: Company Current Liabilities|mannkindcorp.com - Amount of Current Liabilities|AMPH: Company Short-Term Debts|Pacira Pharmaceuticals - Company Short-Term Loans and Borrowings|SPRY (ARS Pharma) - Company Short-Term Debts|Short-Term Debt Theravance Corp TBPH|Company Short-Term Debt scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts TNXP (Tonix Pharmaceuticals Holding Corp.)|Company Short-Term Debts SXT Pharmaceuticals SXTC|EPRX - Company Short-Term Debt|Short-Term Indebtedness BioHarvest Sciences Inc (BHST)|EXOZ (eXoZymes Inc) - Company Current Liabilities|Oramed Pharmaceuticals Inc. (ORMP) - Company Short-Term Debts|ENTX (Entera Bio Ltd) - Company Short-Term Debts|Short-Term Debt MindWalk Holdings, Inc. HYFT|Company Short-Term Debt ABVC BioPharma Inc (ABVC)|Short-Term Debt Volume Cumberland Corp|Quantum BioPharma Ltd - Company Current Liabilities|Amount of Current Liabilities FGEN (fibrogen.com)|Telomir Pharmaceuticals, Inc. - Company Short-Term Debts|Short-Term Debt Volume Rani Therapeutics RANI|SNYR (synergychc.com) - Company Current Liabilities|RLYB (Rallybio) - Company Short-Term Debt|LEXX (Lexaria Bioscience Corp) - Company Short-Term Debts|Short-Term Debt pulmatrix.com PULM|Company Current Liabilities PTHL (Pheton Holdings Ltd)|APM (aptorumgroup.com) - Company Short-Term Loans and Borrowings|Lyra Therapeutics, Inc - Company Current Liabilities|Amount of Current Liabilities IBO (impactbiomedinc.com)|TNF Pharma - Company Short-Term Debts|Company Short-Term Loans and Borrowings YCBD (cbdMD, Inc.)|PRFX: Company Short-Term Debts|Short-Term Debt Altamira Therapeutics Ltd. (CYTO)|Company Short-Term Debt Lipella|OPTN: Company Short-Term Loans and Borrowings|Company Short-Term Debts PIRS|Company Short-Term Debts procapsgroup.com (PROC)|Company Short-Term Debt Petros Pharmaceuticals, Inc. PTPI|QLI (Qilian International Holding Group) - Current Liabilities|ACELYRIN, Inc. - Company Short-Term Debts|Short-Term Debt TFF Pharmaceuticals, Inc